531633 — LINCOLN PHARMACEUTICALS Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for LINCOLN PHARMACEUTICALS, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	922	1,153	1,138	1,524	1,964
Net Total Accounts Receivable
Net Total Receivables	1,464	1,634	1,708	2,160	2,236
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,065	3,528	3,672	4,467	4,999
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1,119	1,476	1,569	1,825	1,860
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	4,594	5,344	5,874	7,003	7,970
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	735	905	723	923	1,062
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	841	1,015	849	1,075	1,253
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	3,753	4,329	5,025	5,928	6,717
Total Liabilities & Shareholders' Equity	4,594	5,344	5,874	7,003	7,970
Total Common Shares Outstanding